Forbes contributors publish independent expert analyses and insights. Scott Hutcheson teaches leadership at Purdue University. Faced with a crowded dining room and dwindling supplies, Cardini ...

The first peer-reviewed journal in the field of human gene therapy, providing all-inclusive coverage of the research, methods, and clinical developments that are driving today's explosion of gene ...

Credit: ImmunityBio. Developed by the Serum Institute of India, the rBCG product, which has been modified to improve its immunogenicity and safety, was evaluated in phase 1/2 clinical trials in Europe ...

Especially for therapies, hurdles remain. One is cost. Casgevy, the CRISPR cure for sickle-cell disease and beta-thalassemia, is expensive to make and to buy. Health-care systems in America and ...

If you use Microsoft PowerPoint, converting a PDF to into a PowerPoint is a great way to make complex documents more digestible for presentations. It doesn't have to be complicated, either. There are ...

The global recombinant DNA technology market was worth at approximately USD 803.76 billion in 2023 and is projected to grow USD 1,623.52 billion by 2034 from USD 856.81 billion in 2024, growing at a ...

Around 2% of the genomes of modern Eurasians contains Neanderthal DNA. Here's how it affects our health. When you purchase through links on our site, we may earn an affiliate commission. Here’s how it ...

This post will show you what to do when your PowerPoint keeps opening off screen on Windows 11/10. Some PowerPoint users have reported that whenever they open the PowerPoint app, it appears outside of ...

Congenital thrombotic thrombocytopenic purpura (TTP) results from severe hereditary deficiency of ADAMTS13. The efficacy and safety of recombinant ADAMTS13 and standard therapy (plasma-derived ...